15 July 2025
Swissmedic: Swiss Biotech Day 2025
At the Swiss Biotech Day 2025 in Basel, key stakeholders from the global life sciences community gathered to discuss the focal topic “The Power of International Collaboration”.
The panel discussion on the topic of “How to reach more patients faster: the promise of international collaboration and shared regulatory approval pathways”, organised by Swissmedic, featured insights from representatives of the pharmaceutical industry on collaborative pathways such as Access Consortium, Project Orbis, and Marketing Authorisation for Global Health Products (MAGHP). Panellists included representatives of Astra Zeneca, Roche and Sintetica.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting